Logo image of LOOP

LOOP INDUSTRIES INC (LOOP) Stock Fundamental Analysis

NASDAQ:LOOP - Nasdaq - US5435181046 - Common Stock - Currency: USD

1.3  -0.09 (-6.47%)

Fundamental Rating

2

Taking everything into account, LOOP scores 2 out of 10 in our fundamental rating. LOOP was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of LOOP have multiple concerns. LOOP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LOOP has reported negative net income.
In the past year LOOP has reported a negative cash flow from operations.
LOOP had negative earnings in each of the past 5 years.
LOOP had a negative operating cash flow in each of the past 5 years.
LOOP Yearly Net Income VS EBIT VS OCF VS FCFLOOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

LOOP has a worse Return On Assets (-81.38%) than 96.47% of its industry peers.
With a Return On Equity value of -4119.35%, LOOP is not doing good in the industry: 94.12% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -81.38%
ROE -4119.35%
ROIC N/A
ROA(3y)-78.72%
ROA(5y)-79.15%
ROE(3y)-1438.32%
ROE(5y)-904.67%
ROIC(3y)N/A
ROIC(5y)N/A
LOOP Yearly ROA, ROE, ROICLOOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LOOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LOOP Yearly Profit, Operating, Gross MarginsLOOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K -20K

3

2. Health

2.1 Basic Checks

LOOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOOP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LOOP has more shares outstanding
Compared to 1 year ago, LOOP has a worse debt to assets ratio.
LOOP Yearly Shares OutstandingLOOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LOOP Yearly Total Debt VS Total AssetsLOOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -12.08, we must say that LOOP is in the distress zone and has some risk of bankruptcy.
LOOP's Altman-Z score of -12.08 is on the low side compared to the rest of the industry. LOOP is outperformed by 88.24% of its industry peers.
LOOP has a Debt/Equity ratio of 36.57. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 36.57, LOOP is doing worse than 94.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 36.57
Debt/FCF N/A
Altman-Z -12.08
ROIC/WACCN/A
WACC7.63%
LOOP Yearly LT Debt VS Equity VS FCFLOOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

LOOP has a Current Ratio of 3.50. This indicates that LOOP is financially healthy and has no problem in meeting its short term obligations.
LOOP has a Current ratio of 3.50. This is amongst the best in the industry. LOOP outperforms 85.88% of its industry peers.
LOOP has a Quick Ratio of 3.48. This indicates that LOOP is financially healthy and has no problem in meeting its short term obligations.
LOOP has a Quick ratio of 3.48. This is amongst the best in the industry. LOOP outperforms 89.41% of its industry peers.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 3.48
LOOP Yearly Current Assets VS Current LiabilitesLOOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

LOOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.18%, which is quite impressive.
LOOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 7111.26%.
EPS 1Y (TTM)68.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%240%
Revenue 1Y (TTM)7111.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%23922.22%

3.2 Future

The Earnings Per Share is expected to grow by 72.47% on average over the next years. This is a very strong growth
Based on estimates for the next years, LOOP will show a very strong growth in Revenue. The Revenue will grow by 169.01% on average per year.
EPS Next Y-57.86%
EPS Next 2Y14.89%
EPS Next 3Y50.85%
EPS Next 5Y72.47%
Revenue Next Year1107.86%
Revenue Next 2Y814.54%
Revenue Next 3Y439.34%
Revenue Next 5Y169.01%

3.3 Evolution

LOOP Yearly Revenue VS EstimatesLOOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
LOOP Yearly EPS VS EstimatesLOOP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

LOOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LOOP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LOOP Price Earnings VS Forward Price EarningsLOOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LOOP Per share dataLOOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

LOOP's earnings are expected to grow with 50.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3Y50.85%

0

5. Dividend

5.1 Amount

No dividends for LOOP!.
Industry RankSector Rank
Dividend Yield N/A

LOOP INDUSTRIES INC

NASDAQ:LOOP (6/27/2025, 10:03:09 AM)

1.3

-0.09 (-6.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-29 2025-05-29/amc
Earnings (Next)07-09 2025-07-09
Inst Owners14.85%
Inst Owner Change-1.97%
Ins Owners1.87%
Ins Owner Change0.32%
Market Cap61.91M
Analysts84.44
Price Target4.01 (208.46%)
Short Float %2.8%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)134.31%
Min EPS beat(2)31.37%
Max EPS beat(2)237.26%
EPS beat(4)3
Avg EPS beat(4)64.92%
Min EPS beat(4)-19.83%
Max EPS beat(4)237.26%
EPS beat(8)5
Avg EPS beat(8)27.84%
EPS beat(12)8
Avg EPS beat(12)31.83%
EPS beat(16)10
Avg EPS beat(16)21.91%
Revenue beat(2)2
Avg Revenue beat(2)17984.2%
Min Revenue beat(2)142.76%
Max Revenue beat(2)35825.6%
Revenue beat(4)2
Avg Revenue beat(4)8957.46%
Min Revenue beat(4)-92.16%
Max Revenue beat(4)35825.6%
Revenue beat(8)3
Avg Revenue beat(8)4486.3%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.42%
PT rev (3m)-0.42%
EPS NQ rev (1m)36.36%
EPS NQ rev (3m)36.36%
EPS NY rev (1m)12.46%
EPS NY rev (3m)12.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-16.59%
Revenue NY rev (3m)-16.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.69
P/FCF N/A
P/OCF N/A
P/B 168.68
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.23
BVpS0.01
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -81.38%
ROE -4119.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-78.72%
ROA(5y)-79.15%
ROE(3y)-1438.32%
ROE(5y)-904.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 36.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.88%
Cap/Sales 4.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.5
Quick Ratio 3.48
Altman-Z -12.08
F-Score5
WACC7.63%
ROIC/WACCN/A
Cap/Depr(3y)443.31%
Cap/Depr(5y)599.55%
Cap/Sales(3y)1434.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%240%
EPS Next Y-57.86%
EPS Next 2Y14.89%
EPS Next 3Y50.85%
EPS Next 5Y72.47%
Revenue 1Y (TTM)7111.26%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%23922.22%
Revenue Next Year1107.86%
Revenue Next 2Y814.54%
Revenue Next 3Y439.34%
Revenue Next 5Y169.01%
EBIT growth 1Y73.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.1%
EBIT Next 3Y39.92%
EBIT Next 5Y89.44%
FCF growth 1Y89.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.25%
OCF growth 3YN/A
OCF growth 5YN/A